Clinical Trials
5 trialsNCT00003245 2018-11-15
Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00003368 2013-03-21
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
National Cancer Institute (NCI)
Phase 1 Completed
NCT00002759 2013-02-05
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003970 2013-01-24
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005626 2012-09-25
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed